This company has been marked as potentially delisted and may not be actively trading. DFP Healthcare Acquisitions (DFPH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock DFPH vs. ELMD, LNSR, TIL, PDEX, XGN, ENTA, CCCC, THTX, MOLN, and BSGMShould you be buying DFP Healthcare Acquisitions stock or one of its competitors? The main competitors of DFP Healthcare Acquisitions include Electromed (ELMD), LENSAR (LNSR), Instil Bio (TIL), Pro-Dex (PDEX), Exagen (XGN), Enanta Pharmaceuticals (ENTA), C4 Therapeutics (CCCC), Theratechnologies (THTX), Molecular Partners (MOLN), and Biosig Technologies (BSGM). These companies are all part of the "medical" sector. DFP Healthcare Acquisitions vs. Its Competitors Electromed LENSAR Instil Bio Pro-Dex Exagen Enanta Pharmaceuticals C4 Therapeutics Theratechnologies Molecular Partners Biosig Technologies Electromed (NYSE:ELMD) and DFP Healthcare Acquisitions (NASDAQ:DFPH) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, media sentiment, valuation, analyst recommendations and profitability. Which has higher valuation & earnings, ELMD or DFPH? Electromed has higher revenue and earnings than DFP Healthcare Acquisitions. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElectromed$61.44M2.49$5.15M$0.7923.08DFP Healthcare AcquisitionsN/AN/A-$8.34MN/AN/A Does the media prefer ELMD or DFPH? In the previous week, Electromed's average media sentiment score of 0.00 equaled DFP Healthcare Acquisitions'average media sentiment score. Company Overall Sentiment Electromed Neutral DFP Healthcare Acquisitions Neutral Do analysts rate ELMD or DFPH? Electromed currently has a consensus target price of $38.00, indicating a potential upside of 108.45%. Given Electromed's stronger consensus rating and higher possible upside, analysts clearly believe Electromed is more favorable than DFP Healthcare Acquisitions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Electromed 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00DFP Healthcare Acquisitions 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is ELMD or DFPH more profitable? Electromed has a net margin of 11.34% compared to DFP Healthcare Acquisitions' net margin of 0.00%. Electromed's return on equity of 15.71% beat DFP Healthcare Acquisitions' return on equity.Company Net Margins Return on Equity Return on Assets Electromed11.34% 15.71% 13.37% DFP Healthcare Acquisitions N/A -107.60%-1.47% Do insiders & institutionals have more ownership in ELMD or DFPH? 40.8% of Electromed shares are held by institutional investors. 14.0% of Electromed shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility and risk, ELMD or DFPH? Electromed has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500. Comparatively, DFP Healthcare Acquisitions has a beta of 0.03, suggesting that its stock price is 97% less volatile than the S&P 500. SummaryElectromed beats DFP Healthcare Acquisitions on 11 of the 11 factors compared between the two stocks. Get DFP Healthcare Acquisitions News Delivered to You Automatically Sign up to receive the latest news and ratings for DFPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DFPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DFPH vs. The Competition Export to ExcelMetricDFP Healthcare AcquisitionsOffices & Clinics Of Medical Doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$38.53M$33.61M$5.54B$9.43BDividend YieldN/AN/A3.76%4.04%P/E RatioN/AN/A28.2619.78Price / SalesN/A0.60414.9188.86Price / CashN/A54.0335.8558.18Price / Book-1.540.398.115.65Net Income-$8.34M-$7.06M$3.25B$257.97M DFP Healthcare Acquisitions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DFPHDFP Healthcare AcquisitionsN/A$1.34flatN/AN/A$38.53MN/A0.00147,000ELMDElectromed0.9209 of 5 stars$18.16-0.4%$38.00+109.3%+13.7%$152.24M$61.44M24.21160LNSRLENSAR1.2143 of 5 stars$12.92+0.2%$15.00+16.1%+166.3%$151.89M$53.49M-2.66110News CoveragePositive NewsTILInstil Bio2.4228 of 5 stars$23.00-3.6%$119.00+417.4%+106.3%$151.67MN/A-1.93410PDEXPro-Dex1.747 of 5 stars$45.56+0.8%$56.00+22.9%+135.7%$148.29M$64.12M16.24140XGNExagen2.684 of 5 stars$6.89+1.6%$7.50+8.9%+257.1%$147.18M$55.64M-8.23220News CoverageENTAEnanta Pharmaceuticals3.4924 of 5 stars$6.82+3.4%$18.00+164.1%-47.3%$146.35M$67.64M-1.51160Positive NewsCCCCC4 Therapeutics2.4732 of 5 stars$2.08-1.7%$12.00+478.3%-61.5%$145.93M$35.58M-1.40150News CoverageGap UpTHTXTheratechnologiesN/A$3.16+0.5%N/A+101.3%$145.07M$84.38M-16.61140MOLNMolecular Partners2.9671 of 5 stars$3.55-0.1%$12.00+238.5%-44.9%$143.55M$5.65M-1.85180Positive NewsBSGMBiosig Technologies1.9033 of 5 stars$5.26+14.7%$10.00+90.3%+955.9%$143.11M$26K0.0050High Trading Volume Related Companies and Tools Related Companies ELMD Competitors LNSR Competitors TIL Competitors PDEX Competitors XGN Competitors ENTA Competitors CCCC Competitors THTX Competitors MOLN Competitors BSGM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DFPH) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DFP Healthcare Acquisitions Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DFP Healthcare Acquisitions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DFPH Stock Alerts